| Stable CAD (n = 56) | ACS (n = 36) | P |
---|---|---|---|
Age (years) | 70.4 ± 5.9 | 67.8 ± 9.2 | 0.171 |
Sex (male, n, %) | 36 (64.3) | 25 (69.4) | 0.609 |
Hypertension (n, %) | 49 (87.5) | 23 (63.9) | 0.365 |
Systolic BP (mmHg) | 137.8 ± 19.6 | 137.0 ± 16.6 | 0.827 |
Current nicotine use (n, %) | 9 (16.1) | 10 (27.8) | 0.176 |
Total pack years (pack years) | 17.1 ± 22.2 | 18.2 ± 17.3 | 0.796 |
Positive family history (n, %) | 25 (44.6) | 12 (33.3) | 0.280 |
Hyperlipidaemia (n, %) | 39 (69.6) | 23 (63.9) | 0.566 |
BMI (kg/m2) | 30.8 ± 4.6 | 29.4 ± 6.0 | 0.218 |
COPD (n, %) | 6 (10.7) | 5 (13.9) | 0.647 |
Known CAD (n, %) | 20 (35.7) | 13 (36.1) | 0.969 |
Previous PCI (n, %) | 14 (25.0) | 13 (36.1) | 0.559 |
Previous CABG (n, %) | 2 (3.6) | 1 (2.8) | 0.834 |
Diabetes severity | |||
 Duration of diabetes (years) | 11.4 ± 9.5 | 11.3 ± 10.5 | 0.943 |
 History of diabetic retinopathy (n, %) | 10 (17.9) | 8 (22.2) | 0.606 |
 History of diabetic neuropathy (n, %) | 20 (35.7) | 8 (22.2) | 0.170 |
 HbA1c (%) | 7.2 ± 1.6 | 7.7 ± 1.8 | 0.008 |
Lab values | |||
 Total cholesterol (mg/ml) | 191.2 ± 45.1 | 187.1 ± 44.3 | 0.667 |
 LDL-cholesterol (mg/ml) | 117.8 ± 36.4 | 113.0 ± 36.2 | 0.543 |
 HDL-cholesterol (mg/ml) | 44.2 ± 10.3 | 42.5 ± 12.4 | 0.472 |
 Triglycerides (mg/dl) | 181.8 ± 103.2 | 165.4 ± 95.2 | 0.454 |
 eGFR (ml/min/1.73 m2) | 58.8 ± 6.5 | 58.1 ± 6.4 | 0.620 |
 BUN (mg/dl) | 40.6 ± 14.5 | 40.2 ± 16.5 | 0.899 |
 Serum Creatinine (mg/dl) | 1.0 ± 0.2 | 1.0 ± 0.3 | 0.927 |
 CRP (mg/ml) | 9.3 ± 11.6 | 20.1 ± 31.6 | 0.057 |
 Creatine kinase at admission (U/l) | 102.9 ± 60.1 | 190.1 ± 158.3 | 0.003 |
 LDH (U/l) | 213.2 ± 66.4 | 245.4 ± 82.0 | 0.046 |
 Maximal troponin T (ng/ml) | NA | 487.4 ± 579.5 | NA |
 Maximal CK (U/l) | NA | 283.1 ± 215.7 | NA |
 Maximal CK-MB (U/l) | NA | 84.0 ± 16.9 | NA |
Medication pre-OCT | |||
 Aspirin (n, %) | 52 (92.9) | 32 (88.9) | 0.510 |
 Betablocker (n, %) | 46 (82.1) | 25 (71.4) | 0.230 |
 ACE-i or ARB (n, %) | 39 (72.2) | 24 (68.8) | 0.711 |
 Insulin (n, %) | 26 (46.6) | 14 (38.9) | 0.476 |
 Metformin (n, %) | 37 (66.1) | 22 (61.1) | 0.628 |
 Sulfonylureas (n, %) | 13 (23.2) | 5 (13.9) | 0.271 |
 Incretins (n, %) | 12 (21.4) | 6 (16.7) | 0.574 |
 Statin (n, %) | 40 (71.4) | 22 (61.1) | 0.354 |
Plaque features in OCT | |||
 Minimal FCT (µm) | 80.4 ± 27.0 | 51.3 ± 9.4 | < 0.001 |
 Mean FCT (µm) | 125.7 ± 29.5 | 97.2 ± 18.0 | < 0.001 |
 Lipid volume index (mm*°) | 493.8 ± 361.1 | 1105.4 ± 343.8 | < 0.001 |
 Presence of macrophages (n,  %) | 23 (41.1) | 25 (69.4) | 0.002 |